NEW BRUNSWICK, NJ (Dec. 17, 2014) - Johnson & Johnson (NYSE: JNJ) will host a conference call at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 20, to discuss fourth-quarter and full-year 2014 financial results. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic J. Caruso, Vice President, Finance and Chief Financial Officer; and Louise Mehrotra, Vice President, Investor Relations will host the call.
Investors and other interested parties may access the conference call in the following ways:
- At Johnson & Johnson’s website: www.investor.jnj.com. This earnings webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A webcast and podcast replay will be available approximately two hours after the conference call concludes.
- By telephone: For both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-247-1020. For participants outside the U.S., the dial-in number is 804-419-7662. The conference ID number for all callers is 51855400. A replay of the conference call will be available beginning at approximately 12:00 p.m. on Jan. 20, 2015, and ending at approximately 12:00 a.m. on Jan. 27, 2015. The replay dial-in number for U.S. participants is 855-859-2056. For participants outside the U.S., the replay dial-in number is (404) 537-3406. The replay conference ID number for all callers is 51855400.
- Presentation materials will be available on www.investor.jnj.com.
About Johnson & Johnson
Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,000 employees at more than 270 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
(917) 697-2318 (M)
Amy Jo Meyer